Treatment with TUKYSA was well-tolerated, with a safety profile consistent with previously known profiles of the individual agents
Panacea Biotec receives acceptance from CMSS for supply of bOPV
Miels will formally assume the role on January 1, 2026
The Moderna Innovation and Technology Centre in Harwell, Oxfordshire is now fully operational and Moderna is licensed to supply British-made COVID-19 vaccines to the UK population
The expansion, supported by a significant UK government grant, includes a new lipid system synthesis facility and enhanced R&D capabilities
The products include high-quality, advanced anti-infective formulations such as EMROK (Levonadifloxacin) and MIQNAF (Nafithromycin)
As with any medicine, the MHRA will keep the safety of gepotidacin under close review
Subscribe To Our Newsletter & Stay Updated
